The Role of Azacitidine in the Treatment of Elderly Patients with Acute Myeloid Leukemia: Results of a Retrospective Multicenter Study
Makaleler > Tam Makale · 2016
Yazarlar: Anil Tombak, Mehmet Ali Ucar, Aydan Akdeniz, Eyup Naci Tiftik, Deniz Goren Sahin, Olga Meltem Akay, Murat YILDIRIM, Oral NEVRUZ, Cem Kis, EMEL GÜRKAN, Serife Medeni Solmaz, Mehmet Ali Ozcan, Rahsan Yildirim, Ilhami Berber, Mehmet Ali Erkurt, Tulin Firatli Tuglular, Pinar Tarkun, Irfan Yavasoglu, Mehmet Hilmi Dogu, Ismail Sari, Mustafa Merter, Muhit Ozcan, Esra Yildizhan, Leylagul Kaynar, Ozgur Mehtap, Ayse UYSAL, Fahri ŞAHİN, Ozan Salim, Mehmet Ali Sungur
TURKISH JOURNAL OF HEMATOLOGY, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2016, cilt 33, ss 273-280
Özet
Objective: In this study, we aimed to investigate the efficacy and safety of azacitidine (AZA) in elderly patients with acute myeloid leukemia (AML), including patients with >30% bone marrow (BM) blasts.